1-4 of 4
VE Paton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P4-22-08: A single-arm phase 2 study to assess clinical activity, efficacy and safety of enzalutamide with trastuzumab in HER2+ AR+ metastatic or locally advanced breast cancer

I Krop, J Cortes, K Miller, MT Huizing, L Provencher, L Gianni, S Chan, M Trudeau, J Steinberg, J Sugg, M Liosatos, VE Paton, A Peterson, A Wardley
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P4-22-08.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-P4-22-08
Published: 15 February 2017
View article
Journal Articles

Abstract OT3-02-02: ENDEAR: A randomized international phase 3 study comparing the efficacy and safety of enzalutamide in combination with paclitaxel chemotherapy or as monotherapy vs placebo with paclitaxel in patients with advanced diagnostic-positive triple-negative breast cancer

R Dent, P Schmid, J Cortes, S-B Kim, F Andre, V Abramson, F Cardoso, M Colleoni, P Morris, J Steinberg, IC Tudor, H Uppal, VE Paton, A Peterson, TA Traina
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): OT3-02-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-OT3-02-02
Published: 15 February 2017
View article
Journal Articles

Abstract P3-07-25: Improved clinical outcomes on enzalutamide observed in patients with PREDICT AR+ triple-negative breast cancer: prognosis or prediction?

K Miller, I Krop, L Schwartzberg, V Abramson, L Garcia-Estevez, J Eakle, R Nanda, D Yardley, F Ademuyiwa, S Chan, J Crown, M Danso, K Gelmon, L Ma, N Martinez-Janez, W Gradishar, J Steinberg, IC Tudor, H Uppal, VE Paton, J Parker, CA Hudis, TA Traina
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P3-07-25.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-P3-07-25
Published: 15 February 2016
View article
Journal Articles

OT3-01-11: A Randomized, Phase II Multicenter, Double-Blind, Placebo-Controlled Trial Evaluating MetMAb and/or Bevacizumab in Combination with Weekly Paclitaxel in Patients with Metastatic Triple-Negative Breast Cancer.

BR Daniel, M Campone, V Dieras, T Ervin, W Yu, VE Paton, Q Xia, A Peterson
Journal: Cancer Research
Cancer Res (2011) 71 (24_Supplement): OT3-01-11.
DOI: https://doi.org/10.1158/0008-5472.SABCS11-OT3-01-11
Published: 15 December 2011
View article